TARRYTOWN, N.Y., Nov. 12,
2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:
REGN) will webcast management presentations as follows:
- Guggenheim Healthcare Talks Idea Forum, Neuro/Immunology Day,
at 11:15 a.m. EST on Monday, November 18,
2019
- Piper Jaffray 31st
Annual Healthcare Conference at 8:00 a.m. EST on Tuesday, December 3, 2019
The sessions may be accessed from the "Investors &
Media" page of Regeneron's website at
http://investor.regeneron.com/events-and-presentations.
Replays of the webcasts will be archived on the Company's website
for at least 30 days.
About Regeneron Pharmaceuticals, Inc.
Regeneron is a
leading biotechnology company that invents life-transforming
medicines for people with serious diseases. Founded and led
for 30 years by physician-scientists, our unique ability to
repeatedly and consistently translate science into medicine has led
to seven FDA-approved treatments and numerous product candidates in
development, all of which were homegrown in our laboratories.
Our medicines and pipeline are designed to help patients with eye
diseases, allergic and inflammatory diseases, cancer,
cardiovascular and metabolic diseases, infectious diseases, pain
and rare diseases.
Regeneron is accelerating and improving the traditional drug
development process through its proprietary
VelociSuite® technologies, such as
VelocImmune® which produces optimized fully-human
antibodies, and ambitious research initiatives such as the
Regeneron Genetics Center, which is conducting one of the largest
genetics sequencing efforts in the world.
For additional information about the company, please visit
www.regeneron.com or follow @Regeneron on Twitter.
Contact Information:
Investor Relations
Justin Holko
914.847.7786
justin.holko@regeneron.com
Corporate Communications
Hala Mirza
914.847.3422
hala.mirza@regeneron.com
View original
content:http://www.prnewswire.com/news-releases/regeneron-announces-upcoming-investor-conference-presentations-300955713.html
SOURCE Regeneron Pharmaceuticals, Inc.